ACTIVE

Novo Nordisk Belgium Manufacturing Holding SA

Financial year 2025 · Closed on 31/12/2025

Net result-45,7 M €-6 729,2 %over 1 year

Equity81,6 M €-35,9 %over 1 year

Identity

Source · BCE/KBO

Novo Nordisk Belgium Manufacturing Holding SA is a Public limited company incorporated in 1995. Its registered office is in Bruxelles.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0455.204.073
Incorporation: 28/04/1995
Legal form: Public limited company
Registered office: Font Saint Landry 10
1120 Bruxelles · BruxellesSee on map
Contributed capital: 216 036 103,00 €
Latest accounts: 31/12/2025

Joint committees (1)

Signals

Solid equity

Financials

Source · NBB, 22 filings

Trend over 14 financial years

	2025		2024		2023		2022		2018
Income statement
EBITDA	-79,2 k €	+30.9%	-114,5 k €	-1514%	-7,1 k €	+37.8%	-11,4 k €	-0.8%	-11,3 k €
Operating result	-79,2 k €	+30.9%	-114,5 k €	-1514%	-7,1 k €	+37.8%	-11,4 k €	-0.8%	-11,3 k €
Net result	-45,7 M €	-6729%	689,2 k €	+63.6%	421,3 k €	+100%	-110,3 M €	-31369%	352,6 k €
Balance sheet
Equity	81,6 M €	-35.9%	127,3 M €	+0.5%	126,6 M €	+0.3%	126,2 M €	+42.4%	88,6 M €
Total assets	81,9 M €	-35.9%	127,6 M €	+0.7%	126,7 M €	+0.4%	126,3 M €	+42.5%	88,6 M €
Cash	234,8 k €	+1171%	18,5 k €	-99.9%	19,3 M €	+15640%	122,5 k €	+4379%	2,7 k €
Debts	258,2 k €	-26.5%	351,4 k €	+129%	153,4 k €	+69.0%	90,7 k €		–

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 19 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Cengic DZENANA	Managing director01/09/2025 → 10/06/2031
Geoffroy BECKERS	Managing director25/06/2025 → 10/06/2031
Sabine CARLINO	Director25/06/2025 → 10/06/2031
Andrew FINNEGAN	Director18/12/2024 → 10/06/2031
Erik, Lorin RASMUSSEN	Director18/12/2024 → 10/06/2031
John KUCKELMAN	Director18/12/2024 → 10/06/2031

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Bruno STUTZMANN	Director17/12/2024 → 18/11/2025
Ramon CERON	Managing director12/12/2023 → 18/11/2025

Other companies at this address

Font Saint Landry 10 1120 Bruxelles

Company	CBE no.
Novo Nordisk Production Belgium SA● Active	0465.935.738

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	31/12/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	18 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/07/2026	19/12/2024	22/12/2023	14/12/2022	28/01/2022	24/12/2020
General meeting	01/07/2026	17/12/2024	22/12/2023	13/12/2022	14/01/2022	24/11/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 22 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	01/07/2026	31/07/2026	French	PDF
Full model	30/06/2024	17/12/2024	19/12/2024	French	PDF
Full model	30/06/2023	22/12/2023	22/12/2023	French	PDF
Full model	30/06/2022	13/12/2022	14/12/2022	French	PDF
Full model	30/06/2021	14/01/2022	28/01/2022	French	PDF
Full model	30/06/2020	24/11/2020	24/12/2020	French	PDF
Full model	30/06/2019	13/12/2019	20/12/2019	French	PDF
Full modelCorrection	30/06/2018	20/11/2018	29/01/2019	French	PDF
Full model	30/06/2018	20/11/2018	05/12/2018	French	PDF
Full model	30/06/2017	21/11/2017	14/12/2017	French	PDF
Full modelCorrection	30/06/2016	15/11/2016	22/02/2017	French	PDF
Full model	30/06/2016	15/11/2016	20/12/2016	French	PDF
Full model	30/06/2015	17/11/2015	25/01/2016	French	PDF
Full model	30/06/2014	18/11/2014	17/12/2014	French	PDF
Full model	30/06/2013	19/11/2013	09/01/2014	French	PDF
Full model	30/06/2012	26/02/2013	27/02/2013	French	PDF
Full model	30/06/2011	15/11/2011	20/12/2011	French	PDF
Full model	30/06/2010	16/11/2010	25/01/2011	French	PDF
Full model	30/06/2009	17/11/2009	17/12/2009	French	PDF
Full model	30/06/2008	18/11/2008	12/12/2008	French	PDF
Full model	30/06/2007	31/01/2008	25/06/2008	French	PDF
Full model	30/06/2006	21/12/2006	28/06/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 19 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Cengic DZENANA	Managing director01/09/2025 → 10/06/2031
Geoffroy BECKERS	Managing director25/06/2025 → 10/06/2031
Sabine CARLINO	Director25/06/2025 → 10/06/2031
Andrew FINNEGAN	Director18/12/2024 → 10/06/2031
Erik, Lorin RASMUSSEN	Director18/12/2024 → 10/06/2031
John KUCKELMAN	Director18/12/2024 → 10/06/2031

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Bruno STUTZMANN	Director17/12/2024 → 18/11/2025
Ramon CERON	Managing director12/12/2023 → 18/11/2025

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates09/09/2026
Démission et nomination d'un administrateur et du commissaire
PDF
Capital / shares08/07/2026
CAPITAL, ACTIONS
PDF
Mandates10/12/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DENOMINATION
PDF
Mandates15/10/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates26/09/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates21/08/2025
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - DIVERS
PDF
Other07/07/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - ASSEMBLEE GENERALE
PDF
Mandates21/03/2025
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings14 filings

Mandates

Cengic DZENANA

Geoffroy BECKERS

Sabine CARLINO

John KUCKELMAN

Erik, Lorin RASMUSSEN

Andrew FINNEGAN

Ramon CERON

Bruno STUTZMANN

Ricardo ZAYAS RIVERA

Thomas CASTELLANO

Steven FASMAN

Wim Joseph BLENDEMAN

and 13 more mandates

1995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031

Novo Nordisk Belgium Manufacturing Holding SACATALENT BELGIUM HOLDING

Font Saint Landry 10, 1120 Neder-Over-Heembeek

Managing director

Director

Managing director

Director

Managing director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Font Saint Landry 10, 1120 Neder-Over-HeembeekCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00363449

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Novo Nordisk Belgium Manufacturing Holding SACurrent	accounts 2025	Accounts 2025 · 2026-00363449
CATALENT BELGIUM HOLDING	accounts 2008 → 2024	Accounts 2024 · 2024-00619711

Events

2025
Annual accounts 2025-45,7 M €↓
2025
Name changeNovo Nordisk Belgium Manufacturing Holding SA
01/09/2025
nominationDzenana Cengic · administrateur
31/08/2025
nominationDzenana Cengic · administrateur délégué
25/06/2025
nominationGeoffroy Beckers · administrateur
25/06/2025
nominationSabine Carlino · administrateur
28/01/2025
nominationBruno Stutzmann · administrateur
28/01/2025
nominationRamon Ceron · administrateur
28/01/2025
nominationGrant Thornton Réviseurs d’ Entreprises · commissaire
18/12/2024
nominationErik Lorin Rasmussen · administrateur
18/12/2024
nominationJohn Kuckelman · administrateur
18/12/2024
nominationJonas Emil Kongshoj · administrateur
18/12/2024
nominationAndrew Finnegan · administrateur
18/12/2024
nominationBruno Stutzmann · administrateur
2024
Annual accounts 2024689,2 k €↑
22/12/2023
nominationRamon Javier Ceron · administrateur
12/12/2023
demissionCeron Ramon · administrateur
2023
Annual accounts 2023421,3 k €↑
28/04/2023
nominationRicardo Zayas Rivera · administrateur
13/12/2022
nominationBruno Stutzmann · administrateur
2022
Annual accounts 2022-110,3 M €↓
29/06/2022
augmentation_capital
2018
Annual accounts 2018352,6 k €↓
2016
Annual accounts 2016448,3 k €↑
2015
Annual accounts 2015427,2 k €↓
2014
Annual accounts 2014437,5 k €↑
2013
Annual accounts 2013304,2 k €↓
2012
Annual accounts 2012357,6 k €↓
2011
Annual accounts 20112,5 M €↓
2010
Annual accounts 20105,1 M €↓
2009
Annual accounts 20097,7 M €↑
2008
Annual accounts 2008-9,7 k €
28/04/1995
IncorporationPublic limited company

Novo Nordisk Belgium Manufacturing Holding SA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events